VCEL
Biotechnology · Healthcare
CFO
Head of Investor Relations
Biogen Inc. (BIIB)Equibles does not estimate personal net worth.
Get an email with a short summary when Vericel Corp publishes a filing, an earnings call transcript or a press release.
Get VCEL alertsJoe Mara is recorded as CFO at Vericel Corp (VCEL) and Head of Investor Relations at Biogen Inc. (BIIB). The proxy statement of Vericel Corp reports total compensation of $3,242,362 for Joe Mara in fiscal 2025, including a base salary of $525,000. Disclosed compensation is on record for 5 fiscal years. Joe Mara has spoken on 24 earnings calls and 2 other investor events across 2 companies, most recently for Vericel Corp on November 5, 2026. Those appearances were for Vericel Corp (VCEL) and Biogen Inc. (BIIB). Vericel Corp is classified in the Biotechnology industry within the Healthcare sector. Biogen Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Vericel Corp includes Joseph A. Mara (CFO), Michael Halpin (COO), Sean C. Flynn (General Counsel) and 7 others.
“Total revenue in the third quarter increased 26% to $85.4 million, significantly above our guidance range, driven by strength across both commercial franchises.”
“Yeah, so Nick touched on some of this, but, you know, we've talked about in our midterm targets, you know, we think we can get to the high 70% range from a gross margin perspective, the high 30% range adjusted EBITDA.”
“The company had a very strong second quarter across all key financial measures, including top-line revenue, bottom-line profitability, and cash generation metrics.”
“I would say just to build off where Nick started, I think we feel like from a commercial perspective, we just feel like the team's been operating and really executing at a very high level over the last few quarters.”
“As Nick referenced, from a financial perspective, the company had its strongest first quarter to date across all key financial measures, including top-line revenue, bottom-line profitability, and cash generation metrics.”
VCEL
Biotechnology · Healthcare
CFO
BIIB
Drug Manufacturers - General · Healthcare
Head of Investor Relations
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vericel Corp (VCEL) | Chief Financial Officer | $525,000 | $3,242,362 |
| 2024 | Vericel Corp (VCEL) | Chief Financial Officer | $505,000 | $2,974,002 |
| 2023 | Vericel Corp (VCEL) | Chief Financial Officer | $475,000 | $2,147,765 |
| 2022 | Vericel Corp (VCEL) | Chief Financial Officer | $440,000 | $2,389,320 |
| 2021 | Vericel Corp (VCEL) | Chief Financial Officer | $383,077 | $5,772,683 |